Search

Dr. Warner took on a larger role in launching a program that brought together EMS and hospitals to speed treatment for people in Dallas who experience a severe type of heart attack known as a STEMI.

With summer approaching and temperatures on the rise, it’s important to protect not just your skin but also your eyes from the sun’s rays.

A compound synthesized by a team led by UT Southwestern scientists kills a range of hard-to-treat cancer types by targeting a previously unexploited vulnerability, a new study reports.

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

UT Southwestern researchers Zhijian “James” Chen, Ph.D., and Sihan Wu, Ph.D., are part of a team that has been awarded a Cancer Grand Challenges grant, a unique award that aims to solve some of cancer’s toughest problems by bringing together global teams with diverse areas of expertise.

Women who were pregnant during the recent Omicron surge were diagnosed with COVID-19 at a much higher rate than during previous phases of the pandemic, but were less likely to develop severe illness, a study by UT Southwestern and Parkland Health scientists found.

The DNA Microarray Core provides centralized access to microarray and related technology for the UT Southwestern research community

Foundation Grants Below is a comprehensive, regularly updated master list of available Awards to support our research faculty's work, studies, or initiatives. To learn more about the foundation grants, visit the Foundation Grants Description page. Use the sortable table below to browse and compare fu…

Esra and team study could lead to personalized therapies based on the KRAS mutation type Published on: February 18, 2026 Dr. Esra Akbay Type of KRAS mutation may guide more effective cancer treatments Esra Akbay, Ph.D., is Associate Professor of Pathology and a member of the Harold C. Simmons Compreh…

The University of Texas Southwestern Medical Center and Parkland Health are consulting the people of the Dallas area on participating in a trauma research study to investigate using one dose of fresh frozen plasma (FFP), the colorless fluid part of blood, to treat patients who suffered a traumatic brain injury.